MedPath

QALSODY

QALSODY

Approved
DIN Number

02555735

Drug Class

Human

Market Date

May 14, 2025

Company
HC

Biogen Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02555735
AIG Number0166545001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07XX22 TOFERSEN
Product Specifications
Dosage FormSolution
Route of AdministrationIntrathecal
AHFS Classification28:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TOFERSENActive
Strength: 100 MG / 15 ML
Monograph: TOFERSEN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.